HISTOGENICS
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.
HISTOGENICS
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.histogenics.com
Total Employee:
51+
Status:
Active
Contact:
(781) 547-4452
Email Addresses:
[email protected]
Total Funding:
209.5 M USD
Technology used in webpage:
Microsoft Exchange Online IPv6 Pound Sterling Microsoft Japanese Yen Microsoft Azure Network Solutions DNS Facebook Like Comcast Akamai Hosted
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
LyGenesis
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-05-16 | ProChon Biotech | ProChon Biotech acquired by Histogenics | N/A |
Investors List
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Histogenics
Split Rock Partners
Split Rock Partners investment in Post-IPO Equity - Histogenics
Precigen
Precigen investment in Post-IPO Equity - Histogenics
BioMed Ventures
BioMed Ventures investment in Series C - Histogenics
Split Rock Partners
Split Rock Partners investment in Series C - Histogenics
Sofinnova Investments
Sofinnova Investments investment in Series C - Histogenics
Foundation Medical Partners
Foundation Medical Partners investment in Series B - Histogenics
Boston Millennia Partners
Boston Millennia Partners investment in Series B - Histogenics
Stryker
Stryker investment in Series A - Histogenics
Howmedica
Howmedica investment in Series A - Histogenics
Official Site Inspections
http://www.histogenics.com
- Host name: wf.networksolutions.com
- IP address: 205.178.189.131
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
